Showing results (51-60 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|November 6, 2018
Herbal Products Regulations in a Few Countries-A Brief OverviewBhavana Brahmananda Bhat, Nayanabhirama Udupa, Dharmagadda SreedharCurrent Drug Discovery Technologies|May 14, 2014
Design and synthesis of new potent inhibitors of farnesyl pyrophosphate synthaseVolodymyr Prokopenko, Vasyl Kovalishyn, Michael Shevchuk, et al.Current Drug Discovery Technologies|June 10, 2008
Genomic signatures for individualized treatment of malignant tumorsM KunzCurrent Drug Discovery Technologies|June 10, 2008
Neurokinin receptors as potential targets in breast cancer treatmentBobby Y Reddy, Katarzyna A Trzaska, Raghav G Murthy, et al.Current Drug Discovery Technologies|June 10, 2008
Biocombinatorial selection of carbohydrate binding agents of therapeutic significanceS A Svarovsky, L JoshiCurrent Drug Discovery Technologies|June 10, 2008
Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugsTatsuo Takahashi-Nishioka, Koichi Yokogawa, Shunji Tomatsu, et al.Current Drug Discovery Technologies|June 10, 2008
Targeting apoptosis to treat multiple sclerosisAndrea L O Hebb, Craig S Moore, Virender Bhan, et al.Current Drug Discovery Technologies|July 17, 2019
Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future ProspectivesPattnaik Subhaswaraj, Asad Syed, Busi SiddhardhaCurrent Drug Discovery Technologies|November 30, 2007
Supramolecular systems-based HPLC for chiral separation of beta-adrenergics and beta-adrenolytics in drug discovery schemesImran Ali, Afzal Hussain, Hassan Y Aboul-Enein, et al.Current Drug Discovery Technologies|November 30, 2007
1H NMR investigations of inclusion complexes between beta-cyclodextrin and 1-hexadecanolHuiming Jiang, Shufen Zhang, Qinglin Guan, et al.Pageof 87